- Telehealth visits
Shreya Agarwal, MD
She | Her | HersPediatric Hematology-Oncology- Telehealth visits
Shreya Agarwal, MD
She | Her | HersPediatric Hematology-Oncology- Telehealth visits
On this page
About me
Dr. Shreya Agarwal is a hematologist who cares for children and young adults with non-malignant blood disorders. She has a particular focus on patients with bleeding and clotting disorders.
In recent years, blood clots have significantly increased among hospitalized children, and are often underdiagnosed, which drives Agarwal's research. She aims to identify people at a high risk of blood clots and develop strategies to prevent and minimize their long-term effects. Her current focus is examining the prevalence and risk factors for blood clots in people with inherited bleeding disorders. Her work has been recognized with several research grants and awards.
Agarwal earned her medical degree from Rajiv Gandhi University of Health Sciences in India. She completed a residency in pediatrics at Rutgers New Jersey Medical School, a fellowship in pediatric hematology and oncology at Baylor College of Medicine and a fellowship in hemostasis and thrombosis at Nationwide Children's Hospital.
Education & training
Board certification
- Pediatric Hematology-Oncology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Peds Hemostasis / Thrombosis, Nationwide Childrens Hospital - GME
- Pediatric Hematology-Oncology, Baylor College of Medicine
Residency
- Pediatrics, Rutgers New Jersey Medical School
Degree
- MD, Rajiv Gandhi Medical College (Mandya)
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
- Pediatric Hematology-Oncology
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.